Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Those enrolled in the federally-run Pre-Existing Condition Insurance Plan (PCIP) now have 2 additional months of coverage, government officials announced. Coverage will continue through March 31, 2014, to ensure people can continue their medical treatment while finding and enrolling in new health plans through state marketplaces/exchanges.
Most women feel some level of pain 1 year after breast cancer surgery, Finnish researchers found. They hope their findings, published in the Journal of the American Medical Association, help inspire new ways of preventing and treating pain to improve quality of life after surgery.
Women at high risk of developing breast cancer should now be able to get medicines to help prevent it at no cost, the U.S. Department of Health and Human Services announced.
Women 65 and older received the same treatment benefit from the combination of pertuzumab (Perjeta), trastuzumab (Herceptin) and docetaxel (Taxotere) as women 64 and younger, a sub-analysis of CLEOPATRA trial data reveals.
Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.
Despite anxiety that can arise from a breast cancer diagnosis, a recent study shows that in the year that follows women may experience post-traumatic growth, or positive changes to the way they view relationships, themselves or their lives.
(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.
People 2 to 24 months post-cancer treatment may find relief from lingering sleep issues that developed during or after treatment by practicing yoga twice a week, a study published in the Journal of Clinical Oncology shows.
An analysis of 10 years of data from the UK Standardization of Breast Radiotherapy (START) trials A and B shows women with early-stage breast cancer may be able to have radiation therapy for a shorter amount of time, yet get the same treatment benefit.
An analysis of 15 years of data from the European Organization for Research and Treatment of Cancer study 10853 shows women with ductal carcinoma in situ (DCIS), the earliest stage of breast cancer, may reduce their risk of the cancer coming back by as much as 50 percent when treated with radiation therapy after lumpectomy.